New Consortium to Develop Drugs for Neglected Tropical Diseases

19-Aug-2009 - Netherlands

A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and leishmaniasis. A total budget of nearly 3.6 million euros has been allocated over the next 4 years, to develop effective drugs for these diseases. The consortium includes IOTA Pharmaceuticals, Mercachem, Nycomed, the Drugs for Neglected Diseases initiative, the Royal Tropical Institute, the University of Bern, the VU University Amsterdam and TI Pharma.

Rob Leurs(VU University Amsterdam), the project's principal investigator, comments: "African sleeping sickness and Leishmaniasis are diseases caused by parasites. Both diseases are prominent on the World Health Organization's list of neglected tropical diseases for which no effective medication is available."

The new consortium will target parasite-specific phosphodiesterase to develop and screen drug candidates for clinical evaluation and the treatment of both diseases. Leurs continues: "This new project combines the knowledge and experience of leading European laboratories and promises to make a major contribution to the treatment of neglected tropical diseases."

Other news from the department science

These products might interest you

Whatman™ folded filter papers

Whatman™ folded filter papers by Cytiva

Whatman folded filter papers

Convenient folded formats speed up your sample preparation

filter papers
Systec H-Series

Systec H-Series by Systec

Safe, reproducible and validatable sterilization of liquids, solids and waste

Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

laboratory autoclaves
Loading...

Most read news

More news from our other portals

So close that even
molecules turn red...